Good morning, Boston. Here are the five things you need to know in Boston business news to start your Thursday, plus scattering your loved one's ashes on the moon.
After more than a decade of developing a microbiome drug, Seres Therapeutics Inc. has won its first FDA approval, Rowan Walrath reports.
In the fourth article in the BBJ's On Main Street series, Lucy Maffei reports that North End restaurateurs are frustrated that they can't offer outdoor dining this summer. They say that after May…
